COMPANY PROFILE

Amalgam Rx

Explore full profile

A digital health company

Wilmington, United StatesFounded 2016Health Tech & Medtech

Valuation $100–250M Last recorded · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Amalgam Rx

Amalgam Rx operates in the digital health sector, focusing on developing and deploying regulated software and algorithms that assist patients and healthcare providers in making informed decisions. The company serves a diverse clientele, including patients, healthcare providers, and clinical trial recruiters, across multiple continents. Amalgam Rx leverages its robust Quality Management System (QMS) and extensive experience with the FDA and other regulatory bodies to ensure compliance and efficacy of its Software as a Medical Device (SaMD) solutions. The business model revolves around creating and scaling digital health solutions that are cleared for use by regulatory authorities, thereby generating revenue through direct sales and partnerships with healthcare organizations and insurers. Amalgam Rx's mission is to empower better healthcare decisions through innovative digital therapeutics and support programs, ultimately transforming care delivery.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Wilmington, United States
Employees: 51
Open positions: None listed
Dealroom signal: 28.7/100
Industry: Health
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Electronic Health Records (EHR), Point of Care, Digital Therapeutics, Hard Tech
Client focus: b2b
Investment activity: 1 company, latest Jan 2021
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBT✓Debt	Aug 2025	$20M	—	Catalio Capital Management	↗
SERIES B✓Equity / VC	Oct 2023	—	—	CVS Health Ventures	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Amalgam Rx website traffic

Latest recorded traffic for Amalgam Rx is 2.9K monthly website visits, up 20.8% over the last three months. Amalgam Rx's team declined 12.1% over the past year.

Latest monthly visits2.9K 3-month web change+20.8% 1-year team growth-12.1%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HCHale CareModern, personalized, fast and accessible women’s health support	Berlin, Germany	Operational	11	$385K	$1.5M
GUGutyCareGutyCare is a digital platform to improve patient support and monitoring in gastroenterology and immunology	Rennes, France	Operational
JUJuliChronic condition management platform that empowers patients and care teams to manage chronic conditions	Boston, United States	Operational
TDTALi DigitalTALi is a digital health company delivering diagnostic and therapeutic solutions for cognitive function and behaviour	Melbourne, Australia	Operational
SESelfBackAI driven digital therapeutics solution providing tailored treatment for low back pain	Odense, Denmark	Operational
PEPerfoodBreakthrough therapeutics at the intersection of software and biotechnology	Lübeck, Germany	Operational
NTNeuroglee TherapeuticsDiscovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases	Singapore, Singapore	Operational
KHKoa HealthLeveraging technology and research to enable people to change their behaviors with effective and accessible support that adapts to their unique circumstances	Barcelona, Spain	Acquired